DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Suzuki S, Sagara K, Otsuka T. , et al.
“Blue letter effects”: changes in physicians' attitudes toward dabigatran after a safety advisory in a specialized hospital for cardiovascular care in Japan.
J Cardiol 2013;
62 (06) 366-373
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.